Back
Alnylam Pharmaceuticals Vs. BridgeBio Pharma Industry Stock Comparison
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
244.97
Seasonality Move:
11.66%
Buy
57
BBIO
BridgeBio Pharma
Last Price:
23.44
Seasonality Move:
10.74%
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $23.42. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $244.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $23.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.65 | Sell |
Relative Strength Index (14 RSI): | 37.82 | Sell |
Chaikin Money Flow: | -229766 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (250.02 - 288.16) | Sell |
Bollinger Bands (100): | (248.72 - 281.72) | Sell |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 43.16 | Sell |
Chaikin Money Flow: | 1274301 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.33 - 25.59) | Sell |
Bollinger Bands (100): | (24 - 27.4) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 245.62 | Sell |
20-day SMA: | 263.27 | Sell |
50-day SMA: | 272.49 | Sell |
200-day SMA: | 211.63 | Buy |
8-day EMA: | 248.36 | Sell |
20-day EMA: | 259.36 | Sell |
50-day EMA: | 265.3 | Sell |
200-day EMA: | 231.03 | Buy |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.4 | Buy |
20-day SMA: | 24.44 | Sell |
50-day SMA: | 24.96 | Sell |
200-day SMA: | 27.29 | Sell |
8-day EMA: | 23.54 | Sell |
20-day EMA: | 24.2 | Sell |
50-day EMA: | 24.92 | Sell |
200-day EMA: | 26.48 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.35 per share, and a decrease next year of $2.41 per share.
Alnylam Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |